Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 3Gastrointestinal 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2Plasma cell 1Other neoplasm 1Myeloid 1Genitourinary 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 87Leukemia, Myelogenous, Chronic, BCR-ABL Positive 71Leukemia, Myeloid, Acute 66Leukemia 64Myeloproliferative Disorders 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Primary Myelofibrosis 39Leukemia, Myeloid, Chronic-Phase 39Leukemia, Myelomonocytic, Chronic 38Polycythemia Vera 32Lymphoma, Non-Hodgkin 29Lymphoma 29Multiple Myeloma 28Leukemia, Lymphocytic, Chronic, B-Cell 28Hodgkin Disease 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Mantle-Cell 25Burkitt Lymphoma 25Leukemia, Myeloid, Accelerated Phase 24Lymphoma, Large-Cell, Immunoblastic 23Lymphoma, Follicular 23Lymphoma, B-Cell, Marginal Zone 23Blast Crisis 23Thrombocythemia, Essential 20Lymphoma, T-Cell, Cutaneous 19Leukemia, Hairy Cell 18Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Anemia, Refractory, with Excess of Blasts 17Neoplasms, Plasma Cell 16Myelodysplastic-Myeloproliferative Diseases 16

Interventions

Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Drug-Related Side Effects and Adverse Reactions × Myeloid × Clear all
NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡